A multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum A (AboBTXA) among women with refractory interstitial cystitis/bladder pain syndrome

Comparing Clinical Efficacy of Botox and Dysport in a Small Group of Patients

(2011) Carl H. Manstein et al.   PLASTIC AND RECONSTRUCTIVE SURGERY

Botox and Dysport: Is there a dose conversion ratio in dermatology and aesthetic medicine?

(2010) Syrus Karsai et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment

(2009) Hsin-Tzu Liu et al.   BJU INTERNATIONAL

INTRA-TRIGONAL INJECTION OF BOTULINUM TOXIN A IN PATIENTS WITH BLADDER PAIN SYNDROME - RESULTS AT 9-MONTHS FOLLOW-UP

(2009) Rui A Pinto et al.   JOURNAL OF UROLOGY

Outcome of a Randomized, Double-Blind, Placebo Controlled Trial of Botulinum A Toxin for Refractory Overactive Bladder

(2009) Michael K. Flynn et al.   JOURNAL OF UROLOGY

Evaluation of health-related quality of life in patients with painful bladder syndrome/interstitial cystitis and the impact of four treatments on it

(2009) Jukka Sairanen et al.   SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY

Botulinum A Toxin Intravesical Injection in Patients With Painful Bladder Syndrome: 1-Year Followup

(2008) Antonella Giannantoni et al.   JOURNAL OF UROLOGY

Diagnostic Criteria, Classification, and Nomenclature for Painful Bladder Syndrome/Interstitial Cystitis: An ESSIC Proposal

(2007) Joop P. van de Merwe et al.   EUROPEAN UROLOGY